https://adneuris.webdancers.com/ 2026-05-21T19:47:07+00:00 https://adneuris.webdancers.com/faqs/ 2026-05-06T20:17:09+00:00 https://adneuris.webdancers.com/about/press-releases/ 2026-02-28T18:14:14+00:00 https://adneuris.webdancers.com/innovation/pipeline/ 2026-05-21T16:05:27+00:00 https://adneuris.webdancers.com/innovation/addiction/ 2026-05-21T19:32:32+00:00 https://adneuris.webdancers.com/innovation/pain/ 2026-05-21T16:08:54+00:00 https://adneuris.webdancers.com/innovation/dual-nmr-moa/ 2026-05-21T16:04:27+00:00 https://adneuris.webdancers.com/about/investors/ 2026-05-14T20:14:56+00:00 https://adneuris.webdancers.com/about/advocacy/ 2026-05-21T15:58:57+00:00 https://adneuris.webdancers.com/about/resources/ 2026-02-28T18:12:34+00:00 https://adneuris.webdancers.com/about/news-events/ 2026-05-14T20:35:40+00:00 https://adneuris.webdancers.com/legal/ 2026-03-03T17:30:22+00:00 https://adneuris.webdancers.com/contact/ 2026-02-28T18:20:38+00:00 https://adneuris.webdancers.com/clinical-trials/ 2026-05-21T19:35:59+00:00 https://adneuris.webdancers.com/innovation/ 2026-05-21T16:02:44+00:00 https://adneuris.webdancers.com/about/ 2026-05-18T15:11:24+00:00 https://adneuris.webdancers.com/privacy/ 2026-03-09T20:58:35+00:00 https://adneuris.webdancers.com/aapm-2026-painconnect-debut-data/ 2026-03-09T21:10:28+00:00 https://adneuris.webdancers.com/aapm-2026-data-debut/ 2026-03-09T21:09:32+00:00 https://adneuris.webdancers.com/nop-mop-new-publication-pain-and-therapy/ 2026-03-09T21:13:39+00:00 https://adneuris.webdancers.com/2025-painweek-phase-3-encore/ 2026-02-25T17:42:57+00:00 https://adneuris.webdancers.com/tris-pharma-debut-intranasal-results-cpdd-2025/ 2026-02-25T17:31:33+00:00 https://adneuris.webdancers.com/positive-phase-3-results-asra-2025/ 2026-02-25T17:47:07+00:00 https://adneuris.webdancers.com/tris-pharma-announces-positive-results-from-alleviate-2-phase-3-pivotal-trial-for-cebranopadol/ 2026-02-25T18:03:41+00:00 https://adneuris.webdancers.com/tris-pharma-presents-new-clinical-data-demonstrating-robust-safety-and-efficacy-of-investigational-first-in-class-therapy-cebranopadol-for-treatment-of-pain/ 2026-02-25T18:06:02+00:00